CORMEDIX INC. Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants
CORMEDIX INC. (CRMD) reported Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants of $2.50 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-25.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants · last filed 2025-03-25
- CORMEDIX INC. stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2017-09-30 was $7.47M.
- CORMEDIX INC. stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2013-06-30 was $0.00.
- CORMEDIX INC. stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2013-03-31 was $507.13K.
- CORMEDIX INC. stock and warrants issued during period, value, preferred stock and warrants for fiscal 2024 was $2.50K.
| Period end | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 3 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 6 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 9 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 12 month |
|---|---|---|---|---|
| 2024-12-31 | $2.50K 10-K · filed 2025-03-25 | |||
| 2017-09-30 | $7.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $3.73M 10-Q · filed 2017-11-09 | ||
| 2017-06-30 | -$3.73M 10-Q · filed 2017-08-09 | |||
| 2013-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2014-03-04 | $507.13K 10-Q/A · filed 2014-03-04 | ||
| 2013-03-31 | $507.13K 10-Q/A · filed 2014-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |